BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 29790383)

  • 1. Focal Treatment for Unilateral Prostate Cancer Using High-Intensity Focal Ultrasound: A Comprehensive Study of Pooled Data.
    Albisinni S; Mélot C; Aoun F; Limani K; Peltier A; Rischmann P; van Velthoven R
    J Endourol; 2018 Sep; 32(9):797-804. PubMed ID: 29790383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes.
    Feijoo ER; Sivaraman A; Barret E; Sanchez-Salas R; Galiano M; Rozet F; Prapotnich D; Cathala N; Mombet A; Cathelineau X
    Eur Urol; 2016 Feb; 69(2):214-20. PubMed ID: 26164416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing High-Intensity Focal Ultrasound Hemiablation to Robotic Radical Prostatectomy in the Management of Unilateral Prostate Cancer: A Matched-Pair Analysis.
    Albisinni S; Aoun F; Bellucci S; Biaou I; Limani K; Hawaux E; Peltier A; van Velthoven R
    J Endourol; 2017 Jan; 31(1):14-19. PubMed ID: 27799004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.
    von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M
    Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients.
    Rischmann P; Gelet A; Riche B; Villers A; Pasticier G; Bondil P; Jung JL; Bugel H; Petit J; Toledano H; Mallick S; Rouvière O; Rabilloud M; Tonoli-Catez H; Crouzet S
    Eur Urol; 2017 Feb; 71(2):267-273. PubMed ID: 27720531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.
    Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A
    Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.
    Cordeiro ER; Cathelineau X; Thüroff S; Marberger M; Crouzet S; de la Rosette JJ
    BJU Int; 2012 Nov; 110(9):1228-42. PubMed ID: 22672199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer.
    Guillaumier S; Peters M; Arya M; Afzal N; Charman S; Dudderidge T; Hosking-Jervis F; Hindley RG; Lewi H; McCartan N; Moore CM; Nigam R; Ogden C; Persad R; Shah K; van der Meulen J; Virdi J; Winkler M; Emberton M; Ahmed HU
    Eur Urol; 2018 Oct; 74(4):422-429. PubMed ID: 29960750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIFU focal therapy for prostate cancer using intraoperatory contrast enhanced ultrasound.
    Claros OR; Tourinho-Barbosa RR; Carneiro A; Collura-Merlier S; Macek P; Lanz C; Cathala N; Prapotnich D; Mombet A; Sanchez-Salas R; Cathelineau X
    Arch Esp Urol; 2019 Oct; 72(8):825-830. PubMed ID: 31579041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Lesion Location and Oncologic Outcomes after Focal Therapy for Localized Prostate Cancer Using Either High Intensity Focused Ultrasound or Cryotherapy.
    Stabile A; Sanchez-Salas R; Tourinho-Barbosa R; Macek P; Pellegrino F; Gandaglia G; Moschini M; Cathala N; Mombet A; Montorsi F; Briganti A; Cathelineau X
    J Urol; 2021 Sep; 206(3):638-645. PubMed ID: 33890485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expected.
    Duwe G; Boehm K; Haack M; Sparwasser P; Brandt MP; Mager R; Tsaur I; Haferkamp A; Höfner T
    World J Urol; 2023 May; 41(5):1293-1299. PubMed ID: 36920492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes.
    Crouzet S; Murat FJ; Pommier P; Poissonnier L; Pasticier G; Rouviere O; Chapelon JY; Rabilloud M; Belot A; Mège-Lechevallier F; Tonoli-Catez H; Martin X; Gelet A
    Radiother Oncol; 2012 Nov; 105(2):198-202. PubMed ID: 23068708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound.
    Ganzer R; Hadaschik B; Pahernik S; Koch D; Baumunk D; Kuru T; Heidenreich A; Stolzenburg JU; Schostak M; Blana A
    J Urol; 2018 Apr; 199(4):983-989. PubMed ID: 29107031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience.
    Reddy D; Peters M; Shah TT; van Son M; Tanaka MB; Huber PM; Lomas D; Rakauskas A; Miah S; Eldred-Evans D; Guillaumier S; Hosking-Jervis F; Engle R; Dudderidge T; Hindley RG; Emara A; Nigam R; McCartan N; Valerio M; Afzal N; Lewi H; Orczyk C; Ogden C; Shergill I; Persad R; Virdi J; Moore CM; Arya M; Winkler M; Emberton M; Ahmed HU
    Eur Urol; 2022 Apr; 81(4):407-413. PubMed ID: 35123819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
    Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
    Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal therapy with high-intensity focused ultrasound for prostate cancer: 3-year outcomes from a prospective trial.
    Kaufmann B; Raess E; Schmid FA; Bieri U; Scherer TP; Elleisy M; Donati OF; Rupp NJ; Moch H; Gorin MA; Mortezavi A; Eberli D
    BJU Int; 2024 Apr; 133(4):413-424. PubMed ID: 37897088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage Hemiablation High Intensity Focused Ultrasound for unilateral radio-recurrent prostate cancer.
    Aoun F; Albisinni S; Biaou I; Peltier A; Limani K; Roumeguère T; van Velthoven R
    Prog Urol; 2019 Oct; 29(12):627-633. PubMed ID: 31400963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
    Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
    Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer.
    van Velthoven R; Aoun F; Marcelis Q; Albisinni S; Zanaty M; Lemort M; Peltier A; Limani K
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):79-83. PubMed ID: 26597660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer.
    Ganzer R; Fritsche HM; Brandtner A; Bründl J; Koch D; Wieland WF; Blana A
    BJU Int; 2013 Aug; 112(3):322-9. PubMed ID: 23356910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.